Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
posted on
Dec 22, 2020 02:00PM
Yes Mazola , lots of crying from the same
Seniors crowd that post fluff all day/everyday,
the ones that try everyday to convince this anonymous board how vast their knowledge of the stock market is...
And we all know you those are..lol
Don and Resverlogix will be just fine ...
GLTA